Bayer, Onyx Win U.S. Approval for Colorectal Cancer Drug

Bayer AG, Germany’s largest drugmaker, and Onyx Pharmaceuticals Inc. won U.S. regulatory approval for an advanced-colorectal cancer drug for patients whose disease progressed after trying standard therapies.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.